Regeneron Pharmaceuticals Inc. (REGN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Regeneron Pharmaceuticals...

    NASDAQ: REGN · Real-Time Price · USD
    556.53
    -1.91 (-0.34%)
    At close: Sep 09, 2025, 3:59 PM
    557.90
    0.25%
    After-hours: Sep 09, 2025, 07:53 PM EDT

    Regeneron Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 2.49B 2.73B 3.11B 2.89B
    Short-Term Investments
    		 6.52B 8.11B 4.64B 2.81B
    Long-Term Investments
    		 8.9B 5.4B 6.59B 6.84B
    Other Long-Term Assets
    		 1.14B 444.1M 336.4M 216.1M
    Receivables
    		 6.21B 5.67B 5.33B 6.04B
    Inventory
    		 3.09B 2.58B 2.4B 1.95B
    Other Current Assets
    		 349.2M 386.6M n/a n/a
    Total Current Assets
    		 18.66B 19.48B 15.88B 14.01B
    Property-Plant & Equipment
    		 4.6B 4.15B 3.76B 3.48B
    Goodwill & Intangibles
    		 1.15B 1.04B 915.5M 6.7M
    Total Long-Term Assets
    		 19.1B 13.6B 13.33B 11.42B
    Total Assets
    		 37.76B 33.08B 29.21B 25.43B
    Account Payables
    		 789.5M 606.6M 589.2M 564M
    Deferred Revenue
    		 627.7M 458.9M 477.9M 442M
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 n/a n/a n/a n/a
    Total Current Liabilities
    		 3.94B 3.42B 3.14B 3.93B
    Long-Term Debt
    		 1.98B 1.98B 1.98B 1.98B
    Other Long-Term Liabilities
    		 1.57B 854.1M 638M 680.2M
    Total Long-Term Liabilities
    		 4.46B 3.68B 3.41B 2.73B
    Total Liabilities
    		 8.41B 7.11B 6.55B 6.67B
    Total Debt
    		 2.7B 2.7B 2.7B 2.7B
    Common Stock
    		 100K 100K 100K 100K
    Retained Earnings
    		 31.67B 27.26B 23.31B 18.97B
    Comprehensive Income
    		 -7.9M -80.9M -238.8M -26.2M
    Shareholders Equity
    		 29.35B 25.97B 22.66B 18.77B
    Total Investments
    		 15.42B 13.51B 11.23B 9.65B

    Add to Watchlist